Good Quality GMP Certification Lincomycin Hydrochloride Capsules
USP Bacteriostatic Antimicrobial
Each capsule contains:
Lincomycin hydrochloride monohydrate equivalent to Lincomycin
Caution: To be dispensed only by or on the prescription of a
Each capsule contains:
Recommended clinical use.
Lincomycin has been shown to have neuromuscular blocking properties
that may enhance the action of other neuromuscular blocking agents.
Therefore it should be used with caution in patients receiving such
Lincomycin should be administered with caution in atopic
Patients with very severe renal disease and/or very severe hepatic
disease accompanied by severe metabolic aberrations should be dosed
with caution, and serum lincomycin levels monitored during
1. Serious infections: 30mg/kg/day divided into 3 or 4 equal doses
2. More severe infections: 60mg/kg/day divided into 3 or 4 equal
When therapy with lincomycin is required in individuals with severe
impairment of renal function, an appropriate dose is 25 to 30% of
that recommended for patients with normally functioning kidneys. In
cases of beta-hemofytic streptococcal infections, treatment should
be continued for at least 10 days.
For optimal absorption it is recommended that nothing be given by
mouth for a period of one to two hours before and after oral
administration of lincomycin.
Severe cardiopulmonary reactions have occurred when this drug has
been given at greater than the recommended concentration and rate.
This product is suitable for sensitive Staphylococcus,
Streptococcus, Streptococcus pneumoniae and anaerobic bacteria
caused by respiratory infections.
Skin and soft tissue infection in female genital tract infection
and pelvic infection and intra-abdominal infection, the latter two
kinds of diseases according to the FDA alone or with other combined
application of antibiotics in addition to.
Indications in patients with application of penicillin, such as
patients with penicillin allergy to penicillin or not.
This product can be used as alternative medicine.
Lincomycin has found to be effective in the treatment of infections
caused by susceptible trains of gram-positive aerobes such as
streptococci, pneumococci and staphyiocci. And also in the
1. Upper respiratory infections including tonsillitis, pharyngitis,
otitismedia, sinusitis, scarlet fever and as adjuvant therapy of
2. Lower respiratory infections including acute bronchitis and
3. Skin & soft tissue infections including celiulitis,
furuncles, abscesses, impetigo, acne and wound infections.
4. Bone & joint infections including osteomyelitis and septic
5. Senpticemia and endocarditis and bacillary dysentery.
Contraindicated in patients haveing known sensitivity towards
lincomycin or clindamycin. Also contraindicated in lactating
LINCOMYCIN is a incosamices antibiotic with the primarily
bacteriostatic action against gram-postive aerobes and a wide range
of anaerobic bacteria , binds to 50s subunit of the bacterial
ribosome similarly to macrolide and inhibites the early stages of
The action of LINCOMYCINE is predominantly bacteriostatic although
high concentration may be slowly bactericidal against sensitivie